基于PRIRATE 2020清单的牙髓病学随机试验报告质量批判性分析
该研究随机抽取2015至2019年PubMed收录的50项牙髓病学随机临床试验,用PRIRATE 2020清单由两名独立评价者评分。结果显示26%为高质量、50%为中等、24%为低质量;欧洲发表、高影响因子期刊、遵循CONSORT及预先注册方案与更高质量相关。
要点
- 牙髓病学随机试验报告存在较多缺陷,仅26%为高质量。
- 欧洲发表、高影响因子期刊、遵循CONSORT、预先注册与高质量相关。
- 作者应遵循PRIRATE 2020指南以提高报告质量。
核心结论
- 牙髓病学领域发表的随机临床试验报告存在大量缺陷,作者应遵循PRIRATE 2020指南以产出高质量报告。
研究设计与样本
- 从PubMed数据库2015至2019年随机选取50项牙髓病学相关随机临床试验,由两名独立评价者依据PRIRATE 2020清单评分。
- 完全报告某条目得1分,未报告得0分,报告不充分得0.5分,不相关条目记为NA。
- 根据总分的四分位距将试验分为低质量(0-58.4%)、中等质量(58.5-72.8%)和高质量(72.9-100%)。
主要发现
- 基于总体评分,13项(26%)为高质量,25项(50%)为中等质量,12项(24%)为低质量。
- 条目1b、6d、11e在所有稿件中均被充分报告,条目5k、5m在所有报告中均评为NA。
- 欧洲发表的报告高质量评分比例显著高于亚洲、中东、北美和南美(P = 0.0002)。
- 高质量报告更常见于影响因子期刊(P = 0.045)、遵循CONSORT指南的期刊(P = 0.008)及预先注册方案的试验(P = 0.003)。
- 临床试验质量与作者数量、期刊类型(牙髓专科 vs. 非牙髓专科)或发表年份无显著差异。
关键数值与推荐
- PRIRATE 2020清单评分:完全报告得1分,未报告得0分,报告不充分得0.5分,不相关记NA。
- 质量分级阈值:低质量0-58.4%,中等质量58.5-72.8%,高质量72.9-100%。
- 显著性水平设定为0.05。
临床怎么用
- 口腔科医生在设计、实施和报告牙髓病学随机临床试验时应遵循PRIRATE 2020清单,减少报告缺陷。
- 优先参考遵循CONSORT指南、预先注册方案且发表于高影响因子期刊的临床试验证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: To critically evaluate the reporting quality of a random sample of clinical trials published in Endodontics against the PRIRATE 2020 checklist and to analyse the association between the quality of reported trials and a variety of parameters. METHODOLOGY: Fifty randomized clinical trials relating to Endodontics were randomly selected from the PubMed database from 2015 to 2019 and evaluated by two independent reviewers. For each trial, a score of '1' was awarded when it fully reported each item in the PRIRATE guidelines whereas a score of '0' was awarded when an item was not reported; when the item was reported inadequately a score of '0.5' was awarded. For the items that were not relevant to the trial, 'Not Applicable (NA)' was given. Based on the interquartile range of the overall scores received, trials were categorized into 'Low' (0-58.4%), 'Moderate' (58.5-72.8%) and 'High' (72.9-100%) quality. The associations between characteristics and quality of clinical trials were investigated. Descriptive statistics, frequency analysis and percentage analyses were used to describe the data. To determine the significance of categorical data, the chi-square test was used. The probability value 0.05 was considered as the level of significance. RESULTS: Based on the overall scores, 13 (26%), 25(50%) and 12 (24%) of the reports of clinical trials were categorized as 'High', 'Moderate' and 'Low' quality, respectively. Three items (1b, 6d, 11e) were adequately reported in all manuscripts whilst two items (5k, 5m) were scored 'NA' in all the reports. The reports published from Europe had a significantly greater percentage of 'High'-quality scores, compared to Asia, Middle East, North America and South America (P = 0.0002). The 'High'-quality reports were published significantly more often in impact factor journals (P = 0.045). Reports of clinical trials published in journals that adhered to the CONSORT guidelines had significantly more 'High' scores compared to those that did not (P = 0.008). Clinical trials with protocols registered a priori had a significantly greater percentage of 'High' scores compared to the trials that were not registered in advance (P = 0.003). No significant difference occurred between the quality of clinical trials and the number of authors, journal (Endodontic specialty vs. Non-Endodontic specialty) or year of publication. CONCLUSIONS: Reports of randomized clinical trials published in the speciality of Endodontics had a substantial number of deficiencies. To create high-quality reports of clinical trials, authors should comply with the PRIRATE 2020 guidelines.
引用
- Nagendrababu V, Jakovljevic A, Jacimovic J, et al. Critical analysis of the reporting quality of randomized trials within Endodontics using the Preferred Reporting Items for RAndomized Trials in Endodontics (PRIRATE) 2020 quality standard checklist. Int Endod J. 2021. PMID: 33544911. doi:10.1111/iej.13489
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。